Patent foramen ovale closure vs. medical therapy alone after cryptogenic stroke in China: A cost-effectiveness analysis

BACKGROUND: In 2019, there were 28. 76 million patients with stroke in China, with ~25% of them suffering from cryptogenic stroke (CS). Patent foramen ovale (PFO) is related to CS, and PFO closure can reduce recurrent stroke. To date, no study has investigated the cost-effectiveness of PFO closure v...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Na, Liu, Bo, Ma, Meijuan, Zhang, Xuejun, Zhang, Wei, Hou, Fangxia, Liu, Fuqiang, Yu, Xiangyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669480/
https://www.ncbi.nlm.nih.gov/pubmed/36407985
http://dx.doi.org/10.3389/fpubh.2022.1016854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669480/
https://www.ncbi.nlm.nih.gov/pubmed/36407985
http://dx.doi.org/10.3389/fpubh.2022.1016854

Ejemplares similares